论文部分内容阅读
女性生殖系统多发性原发肿瘤的发病率约占女性生殖系统肿瘤的1-2%,其中子宫内膜、卵巢原发双癌占50-70%,它在临床上常被误诊为II期卵巢癌或III期子宫内膜癌。随基因诊断的发展,双癌的诊断率可大幅提高,从而有效的指导治疗及预测预后。
Female reproductive system incidence of multiple primary tumors account for about 1-2% of female reproductive system tumors, including endometrial, primary ovarian cancer 50-70%, which is often misdiagnosed as clinical stage II ovary Cancer or stage III endometrial cancer. With the development of genetic diagnosis, the diagnosis rate of double cancer can be greatly improved, which can effectively guide the treatment and predict the prognosis.